Literature DB >> 20537875

Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.

Fumitaka Sato1, Hiroki Tanaka, Faris Hasanovic, Ikuo Tsunoda.   

Abstract

Multiple sclerosis (MS) has been suggested to be an autoimmune demyelinating disease of the central nervous system (CNS), whose primary target is either myelin itself, or myelin-forming cells, the oligodendrocytes. Although axonal damage occurs in MS, it is regarded as a secondary event to the myelin damage. Here, the lesion develops from the myelin (outside) to the axons (inside) "Outside-In model". The Outside-In model has been supported by an autoimmune model for MS, experimental autoimmune (allergic) encephalomyelitis (EAE). However, recently, (1) EAE-like disease has also been shown to be induced by immune responses against axons, and (2) immune responses against axons and neurons as well as neurodegeneration independent of inflammatory demyelination have been reported in MS, which can not be explained by the Outside-In model. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease (TMEV-IDD) is a viral model for MS. In TMEV infection, axonal injury precedes demyelination, where the lesion develops from the axons (inside) to the myelin (outside) "Inside-Out model". The initial axonal damage could result in the release of neuroantigens, inducing autoimmune responses against myelin antigens, which potentially attack the myelin from outside the nerve fiber. Thus, the Inside-Out and Outside-In models can make a "vicious" immunological cycle or initiate an immune cascade. Copyright Â
© 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Year:  2011        PMID: 20537875      PMCID: PMC2937201          DOI: 10.1016/j.pathophys.2010.04.011

Source DB:  PubMed          Journal:  Pathophysiology        ISSN: 0928-4680


  112 in total

Review 1.  Blood-brain barrier disruption in multiple sclerosis.

Authors:  Alireza Minagar; J Steven Alexander
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

2.  Redistribution of cytoskeletal proteins in mammalian axons disconnected from their cell bodies.

Authors:  D F Watson; J D Glass; J W Griffin
Journal:  J Neurosci       Date:  1993-10       Impact factor: 6.167

3.  Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging.

Authors:  R Sharma; P A Narayana; J S Wolinsky
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

4.  Nitric oxide synthase inhibitor, aminoguanidine, reduces inflammation and demyelination produced by Theiler's virus infection.

Authors:  J W Rose; K E Hill; Y Wada; C I Kurtz; I Tsunoda; R S Fujinami; A H Cross
Journal:  J Neuroimmunol       Date:  1998-01       Impact factor: 3.478

5.  Mechanisms of primary axonal damage in a viral model of multiple sclerosis.

Authors:  Jayasri Das Sarma; Lawrence C Kenyon; Susan T Hingley; Kenneth S Shindler
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

6.  Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination.

Authors:  Joseph M Antony; Guido van Marle; Wycliffe Opii; D Allan Butterfield; François Mallet; Voon Wee Yong; John L Wallace; Robert M Deacon; Kenneth Warren; Christopher Power
Journal:  Nat Neurosci       Date:  2004-09-26       Impact factor: 24.884

7.  The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis.

Authors:  Noel G Carlson; Kenneth E Hill; Ikuo Tsunoda; Robert S Fujinami; John W Rose
Journal:  J Neuroimmunol       Date:  2006-03-03       Impact factor: 3.478

8.  Study of the mechanisms by which CD4+ T cells contribute to protection in Theiler's murine encephalomyelitis.

Authors:  P Borrow; C J Welsh; A A Nash
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

9.  The role of myelin in Theiler's virus persistence in the central nervous system.

Authors:  Jean-Pierre Roussarie; Claude Ruffié; Michel Brahic
Journal:  PLoS Pathog       Date:  2007-02       Impact factor: 6.823

10.  Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.

Authors:  B L McRae; C L Vanderlugt; M C Dal Canto; S D Miller
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more
  21 in total

1.  Heterogeneity versus homogeneity of multiple sclerosis.

Authors:  Fumitaka Sato; Nicholas E Martinez; Seiichi Omura; Ikuo Tsunoda
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

2.  PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis.

Authors:  L Mestre; M Redondo; F J Carrillo-Salinas; J A Morales-García; S Alonso-Gil; A Pérez-Castillo; C Gil; A Martínez; C Guaza
Journal:  Br J Pharmacol       Date:  2015-07-14       Impact factor: 8.739

3.  Organ-specific protective role of NKT cells in virus-induced inflammatory demyelination and myocarditis depends on mouse strain.

Authors:  Eiichiro Kawai; Fumitaka Sato; Seiichi Omura; Nicholas E Martinez; Pratap C Reddy; Masaru Taniguchi; Ikuo Tsunoda
Journal:  J Neuroimmunol       Date:  2014-11-08       Impact factor: 3.478

4.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

5.  Neuropathogenesis of Zika Virus Infection : Potential Roles of Antibody-Mediated Pathology.

Authors:  Ikuo Tsunoda; Seiichi Omura; Fumitaka Sato; Susumu Kusunoki; Mitsugu Fujita; Ah-Mee Park; Faris Hasanovic; Richard Yanagihara; Satoshi Nagata
Journal:  Acta Med Kinki Univ       Date:  2016

6.  Two-photon imaging of remyelination of spinal cord axons by engrafted neural precursor cells in a viral model of multiple sclerosis.

Authors:  Milton L Greenberg; Jason G Weinger; Melanie P Matheu; Kevin S Carbajal; Ian Parker; Wendy B Macklin; Thomas E Lane; Michael D Cahalan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-19       Impact factor: 11.205

Review 7.  Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis.

Authors:  Juan Xiao; Rongbing Yang; Sangita Biswas; Yunhua Zhu; Xin Qin; Min Zhang; Lihong Zhai; Yi Luo; Xiaoming He; Chun Mao; Wenbin Deng
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

8.  Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?

Authors:  Nicholas E Martinez; Fumitaka Sato; Seiichi Omura; Alireza Minagar; J Steven Alexander; Ikuo Tsunoda
Journal:  Pathophysiology       Date:  2012-05-26

9.  Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis.

Authors:  Fumitaka Sato; Nicholas E Martinez; Maira Shahid; John W Rose; Noel G Carlson; Ikuo Tsunoda
Journal:  Am J Pathol       Date:  2013-10-01       Impact factor: 4.307

10.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.